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A B S T R A C T
Helicobacter pylori (Hp), a gram-negative, spiral-shaped bacterium is one of the most 
widely spread pathogens in humans, as it concerns half of the world population. Mech-
anisms that allow Hp to cause a life-long infection involve modulation of the immune 
response and host cellular processes which include activation of the innate immune 
response, resistance to phagocytosis, modulation of dendritic cell activity and regu-
latory T cells, and production of proinflammatory cytokines. This is accomplished 
via virulence factors such as colonization factors (a variety of adhesins), factors that 
allow it to evade host defence (flagella and motility, urease system, induction of hy-
pochlorhydria) and factors that are responsible for tissue injury (heat shock proteins 
A and B, vacuolating cytotoxin A, neutrophil activating protein of Hp, and cytotoxin-
associated gene A). The interaction between bacterial effectors, environmental fac-
tors (genetic susceptibility to infection) and factors that modulate the host’s response, 
such as polymorphisms in genes encoding cytokines or cytokine receptors, have been 
shown to influence the clinical outcome of Hp infection either towards peptic ulcer 
and/or cancer. Future studies, directed toward understanding interactions between 
Hp and immune cells in vivo, may lead to the development of novel therapeutic ap-
proaches for eradication of Hp.
I N T R O D U C T I O N
Helicobacter pylori (Hp) is a gram-negative, spiral-shaped pathogenic bacterium 
that colonizes the gastric epithelium and causes chronic gastritis, peptic ulcer and/or 
gastric malignancies including mucosa-associated lymphoid tissue (MALT) lymphomas, 
while most infected people remain asymptomatic.1 These diseases are determined by 
the relationship between virulence factors of bacteria, host factors such as genetic pre-
disposition and immune response.1,2 Regarding genetic predisposition, polymorphism 
in the promoter region of interleukin (IL)-1 and IL-8 receptor have been associated 
with an increased incidence of atrophic gastritis and gastric cancer.3,4 Prevalence among 
adults is 70–90% in many developing countries and 25-50% in industrialized countries.5
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List of AbbreviAtions
AP-1 = activator protein 1
BabA = blood group antigen-binding A
cag = cytotoxin associated genes
cag-PAI = cag pathogenicity island (a 
foreign DNA region in Hp)
cAMP = cyclic adenosine monophosphate
CARD4 = Caspase-activating domain 4
CpG = (DNA molecules that contain a) 
cytosine “C” followed by a guanine 
“G” dinucleotide (“p” refers to the 
phosphodiester backbone of DNA)
CREB-1 = cAMP response element-
binding protein 1
FOXP3 = forkhead box P3 protein
GECs = gastric epithelial cells
Hops = helicobacter outer membrane 
proteins
Hp = Helicobacter pylori
HSP = heat shock protein
IFN-γ = interferon gamma
IL = interleukin
LPS = lipopolysaccharide
MALT = mucosa-associated lymphoid 
tissue
NF-κB = nuclear factor kappa-light-chain-
enhancer of activated B cells
Nod = nucleotide-binding oligomerization 
domain
OipA = outmembrane inflammatory 
protein A
PAMPs = pathogen-associated molecular 
patterns
SabA&B = sialic acid-binding adhesin 
A&B
Th1 = T helper cell type 1
TLR = Toll-like receptor
TNF = tumor necrosis factor
Treg = regulatory T cell
VacA = vacuolating toxin A
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After entering the stomach, Hp evades host defence, im-
munity and gastric mucosa, via virulence colonization and 
other factors (Table 1), including urease activity, motility 
mediated by the flagella, adhesins, membrane engraftment 
of cholesterol, vacuolating toxin A (VacA)-induced T-cell 
suppression, and metal acquisition proteins6-8.
After disruption of epithelial cell junctions, the bacteria can 
pass through the gastric wall facing direct immune response 
from neutrophils, lymphocytes, mast cells and dendritic cells.9-12 
The innate immune response is mainly represented by Toll-
like receptors (TLR) and nucleotide-binding oligomerization 
domain (Nod)-like receptors, that recognize their specific 
ligands, activate transcription factors such as nuclear factor 
kappa-light-chain-enhancer of activated B cells (NF-κB), 
activator protein 1 (AP-1), cyclic adenosine monophosphate 
(cAMP) response element-binding protein 1 (CREB-1), and 
induce production of inflammatory cytokines such as IL -8, 
IL-12, IL-6, IL-1β, IL-18, tumor-necrosis factor-α (TNF-α) 
and IL-10.13-16 Interleukin-1β and TNF-α, which are produced 
locally in the gastric mucosa, are potent inhibitors of gastric 
acid secretion.17
TABle 1. Helicobacter pylori (Hp) related virulence factors and relation to disease
Factors Role Disease Ref
CagA entry to GECs via type IV secretion system
phosphorylation & binding to SHP-2
gastric cytokine production (IL-8)
glycan biosynthesis in GECs 
↑ risk for developing peptic ulcer or gastric 
cancer in Western populations
50 to 70% (+) of Hp strains
18,19
VacA depolarization of the membrane
induction of apoptosis
inhibition of T-lymphocyte activation
disruption of endosomal & lysosomal activity 
50% (+) of Hp strains
↑ risk of peptic ulcer or gastric cancer in Western 
countries, Latin America, Middle East.
20-22
LPS structural homology with Lewis blood group antigens 
X & Y
stimulation of release of cytokines (lymphotoxin a, 
CCL19 and CCL21)
23,24





↑ risk of gastric cancer, intestinal metaplasia, 
corpus atrophy 
26,28
HspA & B adhesion to GECs ↑ risk of MALT lymphoma 29 
AlpA & B Adhesion to GECs and cytokine production 26,29
OipA (HopH) Adhesion to GECs
↑ IL-8 expression
↑ risk of duodenal ulcers and gastric cancer 26,30,31
IceA encodes a restriction endonuclease ↑ risk of peptic ulcer 32,33
DupA ↑ IL-8 production ↑ risk of duodenal ulcers
↓ risk for cancer
34,35
NapA neutrophil recruitment & production of ROS
upregulation of IL-12, IL-23, TNF-a, IFN-γ
36-38
Alp = alkaline phosphatase; Bab = blood group antigen-binding; Cag = cytotoxin-associated antigen; CCL = cytosine-cytosine ligand (protein); 
Dup = duodenal ulcer perforation; GECs = gastric epithelial cells, Hop = Helicobacter outer membrane porins; Hp = Helicobacter pylori; HSPs 
= heat shock proteins; Ice = IL-1beta-converting enzyme; IFN = interferon; IL = interleukin; LPS = lipopolysaccharide; MALT = mucosa 
associated lymphoid tissue; Nap = neutrophil-activating protein; Oip = outmembrane inflammatory protein; Ref = references; ROS = reactive 
oxygen species; SabA = sialic acid-binding adhesin A; SHP = Src homology 2 domain-containing tyrosine phosphatise; TNF = tumor necrosis 
factor; Vac = vacuolating toxin.
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H e l I C O B A C T e R  P y l O R I  R e l A T e D 
v I R U l e N C e  A N D  C O l O N I Z A T I O N 
F A C T O R S
F l A g e l l A  A N D  m O T I l I T y
Helicobacter pylori has been shown to require flagella for 
infection of the stomach. Flagella allow the bacterium to swim 
across the viscous gastric mucus and reach the more neutral 
pH below the mucus.7
U R e A S e  S y S T e m
Helicobacter pylori synthesizes urease constitutively. As 
urease hydrolyses urea to form ammonia and carbon dioxide, 
and ammonia can absorb acid to form ammonium, it is natural 
to suspect that this dedication to make urease has a relation 
to survival and growth in the acidic environment of human 
stomach. There are data showing that the organisms do buffer 
their periplasm that lies between their inner and outer mem-
brane, in acidic pH, using their intrabacterial urease activity.8
A D H e S I N S
Adhesins, such as blood group antigen-binding A (BabA), 
sialic acid-binding adhesin A&B (SabA&B) and outmembrane 
inflammatory protein A (OipA), which are helicobacter outer 
membrane proteins (Hops), enhance adhesion with gastric 
epithelial cells (GECs) by recognizing specific carbohydrate 
structures, such as the Lewis b blood group antigen and gly-
colipids having sialyl dimeric Lewis X, while other virulence 
factors facilitate Hp colonization and proliferation (Table 1).
I m m U N e  A N D  N O N  I m m U N e  R e S P O N S e 
O F  H O S T  C e l l U l A R  P R O C e S S e S
A N T I B A C T e R I A l  P R O P e R T I e S  O F  T H e  H U m A N 
S T O m A C H
The gastric epithelial layer constitutes a physical barrier 
that prevents entry of bacteria into the gastric mucosa. One 
of the most important antibacterial properties of the human 
stomach is its acidic pH, while multiple factors produced by 
the gastric mucosa such as antibacterial peptides are obsta-
cles for Hp colonization and proliferation.39-41 In particular 
the antibacterial peptides produced by the gastric mucosa, 
β-defensins and lactoferrin, inhibit bacterial growth by restrict-
ing the availability of extracellular iron. 39-41
A C U T e  I N F e C T I O N
Gastric biopsies performed 2 weeks after infection showed 
infiltration of lymphocytes and monocytes, along with sig-
nificantly increased expression of IL-1β, IL-8, and IL-6 in the 
gastric antrum.9 Four weeks after infection, the numbers of 
gastric CD4+ and CD8+ T cells seem to increase compared 
to pre-infection levels, indicating the development of an early 
adaptive immune response.10 Either innate immune responses 
to Hp or early adaptive immune responses could account for 
the gastric mucosal inflammatory responses and symptoms 
that accompany acute infection (Fig. 1).
C H R O N I C  I N F e C T I O N
Gastric mucosal biopsies from humans who are persistently 
infected with Hp revealed an increased concentration of vari-
ous types of leukocytes such as lymphocytes (both T cells and 
B cells), macrophages, neutrophils, mast cells and dendritic 
cells, compared to biopsies from uninfected humans, causing 
an inflammatory response called “chronic superficial gastri-
tis”.11,12 Moreover, CD4+ T cells are typically more abundant 
than CD8+ T cells42,43, while T regulatory cells expressing 
forkhead box P3 protein (FOXP3) are usually present in higher 
numbers playing an important role in regulating the inflam-
matory response.42 Various cell types, including B cells and 
CD4+ cells, sometimes organize into lymphoid follicles. The 
chronic gastric mucosal inflammatory response to Hp probably 
reflects the combined effects of a cellular immune response 
and an ongoing stimulation of an innate immune response 
associated with strong IL-12 production leading to a T helper 
cell type 1 (Th1)-polarized response.44,45 Levels of numerous 
cytokines, including IFN-γ, TNF, IL-1β, IL-6, IL-7, IL-8, IL-
10, and IL-18, are increased in the stomachs of Hp infected 
humans compared to uninfected humans.14-16 Helicobacter 
pylori infection always results in a strong immune response of 
the host against the infecting strain, but this response seldom 
(if ever) results in clearance of the infection.
A C T I vA T I O N  O F  T H e  I N N A T e  I m m U N e  R e S P O N S e
Toll-like receptors recognize conserved microbial com-
ponents, termed “pathogen-associated molecular patterns” 
(PAMPs), and play an important role in initiating innate im-
mune responses to bacterial pathogens including Hp. Among 
the TLRs that recognize gram-negative bacteria, some of the 
most extensively characterized include TLR2 (which recog-
nizes lipoproteins), TLR4 [gram-negative lipopolysaccharide 
(LPS)], TLR5 (flagellin), and TLR9 (bacterial CpG DNA 
motifs).23,24 Gastric epithelial cells (GECs) in the antrum and 
the corpus of the human stomach are reported to express 
TLR4, TLR5, and TLR9.46 Although TLR4 is involved in the 
induction of an immune response against Hp47, TLR2 and 
TLR5, rather than TLR4, seem to be the predominant recep-
tors for Hp antigen-induced NF-kB activation and chemokine 
expression in the GECs.48-51 However, compared to other 
gram-negative bacterial antigens, TLRs seem to play only a 
minor role in the induction of the innate immune response 
against Hp.52,53 After activation of TLRs, dendritic cells, in 
turn, activate T cells in different ways, being capable of induc-
ing either a Th1 or Th2/regulatory T cell (Treg) response by 
generation of IL-12 or IL-10, respectively (Fig. 1).54-56 Toll-like 
receptors’ independent mechanisms seem to predominate in 
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the activation of the innate response against Hp. For example 
the recognition of the bacterial heat shock protein (Hsp) 60 
is not mediated via these TLRs.57 The intracellular pepti-
doglycan, transferred into the cytoplasm by cag (cytotoxin 
associated genes) pathogenicity island (cag-PAI)-mediated 
contact between the epithelial cell and the bacterium, may 
be a key activator of the innate response against Hp. This 
intracellular peptidoglycan is recognized by Nod1, a member 
of the recently discovered Nod family also known as CARD4 
(Caspase-activating domain 4) and such recognition probably 
contributes to initiation of an innate immune response in vivo.58
Helicobacter pylori has recently been shown to decrease 
production of specific heat shock proteins (HSPs) in vitro and 
within colonized gastric mucosa.59 Since HSPs can modulate 
both innate and adaptive immune responses, inhibition of HSP 
production may represent an additional mechanism of immune 
evasion that promotes long-term colonization. Helicobacter 
pylori also has the capacity to use cholesterol from its host 
and incorporate this into its membrane which could facilitate 
molecular mimicry.60 Moreover, Hp is capable of inhibiting 
phagocytosis by macrophages resulting not only in reduced 
anti-Hp activity of the macrophages but more importantly in 
decreased and altered processing of Hp antigens by activated 
macrophages.57,61-64
C O N C l U S I O N
Helicobacter pylori (Hp) is one of the most widely spread 
pathogens in humans. Mechanisms that allow Hp to cause a 
life-long infection involve modulation of the immune response 
and host cellular processes. The interaction between bacterial 
FIgURe 1. Innate and adaptive immune response against Helicobacter pylori. Innate immune recognition of Helicobacter pylori 
(Hp), mediated in part through Toll like receptors (TLRs) such as TLR2, TLR4, TLR5, and TLR9, leads to the production of 
proinflammatory cytokines by macrophages, dendritic cells (DCs), mast cells and gastric epithelial cells (GECs). In addition, Hp 
peptidoglycan (PG) can be recognized by intracellular nucleotide-binding oligomerization domain (NOD) receptors such as NOD1. 
Production of interleukin 8 (IL-8) by GECs leads to recruitment of neutrophils (polymorphonuclear leukocytes [PMNs]), which can 
phagocytose opsonized bacteria and produce reactive oxygen species (ROS). Direct interactions between Hp and GECs or Hp con-
stituents can also activate polymorphonuclear (PMN) cells and/or macrophages, which further amplifies the T-cell response to this 
pathogen. Dendritic cells can penetrate the epithelial barrier in vivo and sample Hp antigens directly, leading to an activation of T 
cells in different ways, being capable of inducing either a T helper 1 (Th1), or a Th2/regulatory T cell (Treg), response by generation 
of IL-12 or IL-10, respectively. The activation of mast cells results in degranulation and production of proinflammatory cytokines 
and chemokines.
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effectors, environmental factors and factors that modulate 
the host’s response, have been shown to influence the clini-
cal outcome of Hp infection either towards peptic ulcer and/
or cancer.66 Future studies directed toward understanding 
interactions between Hp and immune cells in vivo may lead 
to the development of novel therapeutic approaches for 
eradication of Hp.
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